ESCV 2023 vs Immuno-Oncology Usage & Stats

In the official congress app you will find: the updated program, speakers, useful information and all the details of the upcoming 25th ESCV Annual Meeting
  • Apple App Store
  • Free
  • Medical

Store Rank

- -

@Point of Care™ with Ask Cognitive AI is a clinical decision-making mobile platform. Immuno-Oncology @Point of Care™ provides a streamlined clinical decision support tool for clinicians to obtain content when it is needed—enabling better decisions, better outcomes, and better care. With Ask Cognitive AI, clinicians use @Point of Care™ to easily access curated, evidence-based, and disease-specific medical content. Clinicians navigate content by asking voice-enabled natural language questions. Cognitive AI provides confidence-rated answers to efficiently incorporate best treatment options happen more quickly and decisions are made faster to improve patient outcomes at the point of care. Immuno-Oncology @Point of Care™ is designed to: • Support discovery and practice change • Provide relevant, evidence-based disease-specific medical content • Improve patient outcomes at the point of care Features: • Continually updated Immuno-Oncology content • Customize your library with over 50 supplemental topics • Topics in diagnosis, treatment, and care management developed with expert physician authors • Case studies, videos, and interviews • Access to actionable patient-recorded data • Detailed reference list with access to original sources • Continuing medical education credit (CME/CE) • Surveys and peer polling • Patient education resources to share with patients
  • Apple App Store
  • Free
  • Medical

Store Rank

- -

ESCV 2023 vs. Immuno-Oncology ranking comparison

Compare ESCV 2023 ranking trend in the past 28 days vs. Immuno-Oncology

Rank

No Data Available

ESCV 2023 vs. Immuno-Oncology ranking by country comparison

Compare ESCV 2023 ranking trend in the past 28 days vs. Immuno-Oncology

No Data to Display

Compare to any site with our free trial

Get started
ESCV 2023 VS.
Immuno-Oncology

December 16, 2024